Navigation Links
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
Date:4/18/2012

ATLANTA, April 18, 2012 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company focused in Women's Health, recently announced the appointment of Michael Sullivan as Vice President, Sales and Marketing.  Sullivan will be responsible for all sales and marketing efforts for Avion.  Avion Pharmaceuticals recently re-launched the PRENATE FAMILY™ of prenatal vitamins, newly reformulated with QUATREFOLIC®, the fourth generation of folic acid.      

Sullivan has more than 20 years of successful prescription pharmaceutical sales and marketing experience, including "start-up" expertise.  

Mike is a graduate of Neumann University and he earned his Master's in Business Administration from Frostburg State University. 

"We are thrilled to have Mike's expertise in the Women's Healthcare category as we build our PRENATE® franchise," said Mark Pugh, CEO of Avion Pharmaceuticals.   "We are looking to Mike to assist us in expanding into other therapeutic categories and advancing our brand presence in the prescription market."

About Avion Pharmaceuticals, LLC.
Avion is a specialty pharmaceutical company that develops and markets a growing portfolio of innovative, branded pharmaceutical and dietary supplement products in the Women's Health and Dermatology areas.  Avion focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available dietary supplement products, therapeutics and late –stage development drugs to fulfill unmet medical and dietary needs.


'/>"/>
SOURCE Avion Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
2. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
3. Optimer Pharmaceuticals, Inc. Announces Presentation at ECCMID of Post-Hoc Subgroup Analysis of DIFICID in Adult Cancer Patients Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
4. Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
7. Tibet Pharmaceuticals, Inc. Announces Intent to Go Private
8. Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico
9. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
10. Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
11. Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... ... as Vice President of Sales and Business Development at OAKWORKS, Inc. Mr. ... engagements, business development, and strategic planning for the company. Recognized industry-wide as ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... An April ... of a pair of ancient teeth, which reveal a great deal about prehistoric ice-age ... a sharp stone may have been used to remove decayed dental matter, and that ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to ... in the 2017 London Marathon. Set to take place on April 23rd, the London Marathon ... Dr. Schwartz will run as part of team EMPOWER, raising money for the international charity, ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Chicago plastic surgeon, ... removal of osteoma. An osteoma is a benign bony lump located on the forehead ... and can cause difficulties with sight and pain. Dr. Shah has discovered an approach ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
Breaking Medicine News(10 mins):